Friday, May 1, 2026

Hyundai Bioscience’s CEO will Join the President’s Economic Delegation to Vietnam

Hyundai Bioscience partners with Bepharco for antiviral drug distribution in Vietnam and accelerates cancer treatment trials.

North Korea’s Healthcare Revolution: New Cancer Treatments and Medical Innovations Unveiled in 2026

North Korea promotes medical modernization, developing cancer treatments and advanced surgical techniques, aiming for a health revolution by 2025.

South Korea’s Health Minister Pledges Swift Action to Prevent Medical Supply Disruptions

Health Minister Jeong Eun-kyung assures swift action to stabilize medical product supplies amid Middle East conflict concerns.

Tag: Dupixent

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

GI Innovation Uses AI to Develop Next-Gen Allergy Drug Aimed at Dupixent’s $15 Billion Market

GI Innovation is advancing an AI-optimized allergy treatment, targeting multiple pathways in atopic dermatitis to rival Dupixent.

Chong Kun Dang Wins European Phase 1 Approval for Dupixent Biosimilar: Advancing CKD-706’s Global Development

Chong Kun Dang's CKD-706 biosimilar for Dupixent received Phase 1 trial approval in Europe, aiming to expand treatment options for inflammatory diseases.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.